---
title: "Q32 Bio Inc. (QTTB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/QTTB.US.md"
symbol: "QTTB.US"
name: "Q32 Bio Inc."
industry: "Biotechnology"
---

# Q32 Bio Inc. (QTTB.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.q32bio.com](https://www.q32bio.com) |

## Company Profile

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.57 | 227/604 | - | - | - |
| PB | -3.58 | 512/604 | 4.36 | 3.63 | 3.19 |
| PS (TTM) | -1.71 | - | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-25T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 67% |
| Overweight | 0 | 0% |
| Hold | 1 | 33% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.43 |
| Highest Target | 20.00 |
| Lowest Target | 3.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/QTTB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/QTTB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/QTTB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.